WallStSmart

Edwards Lifesciences Corp (EW)vsModular Medical Inc (MODD)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

EW leads profitability with a 15.4% profit margin vs 0.0%. EW earns a higher WallStSmart Score of 55/100 (C).

EW

Buy

55

out of 100

Grade: C

Growth: 4.0Profit: 8.0Value: 5.3Quality: 6.0
Piotroski: 3/9Altman Z: 4.48

MODD

Avoid

26

out of 100

Grade: F

Growth: 4.3Profit: 3.0Value: 5.0Quality: 6.0
Piotroski: 1/9Altman Z: -12.19
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

EWUndervalued (+69.3%)

Margin of Safety

+69.3%

Fair Value

$257.97

Current Price

$89.72

$168.25 discount

UndervaluedFair: $257.97Overvalued

Intrinsic value data unavailable for MODD.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EW2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
4.4810/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
29.8%8/10

Strong operational efficiency at 29.8%

MODD2 strengths · Avg: 10.0/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Areas to Watch

EW4 concerns · Avg: 2.8/10
PEG RatioValuation
2.094/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
51.2x2/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-25.4%2/10

Earnings declined 25.4%

MODD4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$12.50M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : EW

The strongest argument for EW centers on Altman Z-Score, Operating Margin. Profitability is solid with margins at 15.4% and operating margin at 29.8%. Revenue growth of 13.6% demonstrates continued momentum.

Bull Case : MODD

The strongest argument for MODD centers on Price/Book, Debt/Equity.

Bear Case : EW

The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 51.2x leaves little room for execution misses.

Bear Case : MODD

The primary concerns for MODD are Revenue Growth, EPS Growth, Market Cap.

Key Dynamics to Monitor

EW profiles as a mature stock while MODD is a value play — different risk/reward profiles.

EW carries more volatility with a beta of 0.85 — expect wider price swings.

EW is growing revenue faster at 13.6% — sustainability is the question.

MODD generates stronger free cash flow (-7M), providing more financial flexibility.

Bottom Line

EW scores higher overall (55/100 vs 26/100), backed by strong 15.4% margins and 13.6% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Edwards Lifesciences Corp

HEALTHCARE · MEDICAL DEVICES · USA

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.

Visit Website →

Modular Medical Inc

HEALTHCARE · MEDICAL DEVICES · USA

Modular Medical, Inc., a development-stage medical device company, focuses on the design, development and marketing of insulin pumps for people with insulin-dependent diabetes. The company is headquartered in San Diego, California.

Visit Website →

Want to dig deeper into these stocks?